Inventor · disambiguated record
Akiko Koide
Also filed as: KOIDE AKIKO
19 granted patents·16 pending applications·113 citations·filing 2002–2024
92Inventor score
Top patents by PatentIndex Score
35 records- 0195US11629191B2Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2022·Granted Apr 18, 2023·4 cites·17 claims
- 0293US10344091B2Anti-Galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2018·Granted Jul 9, 2019·9 cites·30 claims
- 0393US7556925B2ανβ3 integrin-binding polypeptide monobodies and their useUNIV ROCHESTER·Filed 2002·Granted Jul 7, 2009·75 cites·31 claims
- 0491US10450374B2Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2019·Granted Oct 22, 2019·5 cites·20 claims
- 0588US10519236B2Antibodies specific to delta 1 chain of T cell receptorUNIV NEW YORK·Filed 2019·Granted Dec 31, 2019·4 cites·19 claims
- 0686US11680091B2Methods and composition involving thermophilic fibronectin type III (FN3) monobodiesUNIV CHICAGO·Filed 2019·Granted Jun 20, 2023·2 cites·8 claims
- 0785US11414492B2Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2019·Granted Aug 16, 2022·2 cites·30 claims
- 0883US8263350B2Molecular affinity clamp technology and uses thereofKOIDE SHOHEI·Filed 2010·Granted Sep 11, 2012·5 cites·20 claims
- 0980US9885050B2Molecular affinity clamp technology and uses thereofKOIDE SHOHEI·Filed 2008·Granted Feb 6, 2018·4 cites·17 claims
- 1075US9512199B2Fibronectin cradle molecules and libraries thereofLOEW ANDREAS·Filed 2011·Granted Dec 6, 2016·3 cites·5 claims
- 1175US2023295300A1Antibodies specific to delta 1 chain of t cell receptorUNIV NEW YORK·Filed 2023·Application pending·0 cites
- 1274US2025333506A1Antibodies specific to delta 1 chain of t cell receptorUNIV NEW YORK·Filed 2024·Application pending·0 cites
- 1371US12312392B2Methods and composition involving thermophilic fibronectin type III (FN3) monobodiesUNIV CHICAGO·Filed 2023·Granted May 27, 2025·0 cites·12 claims
- 1469US11673952B2Antibodies specific to delta 1 chain of T cell receptorUNIV NEW YORK·Filed 2019·Granted Jun 13, 2023·0 cites·26 claims
- 1568US12391770B2Compositions and methods comprising antibodies that bind to covalent peptide conjugatesUNIV NEW YORK·Filed 2024·Granted Aug 19, 2025·0 cites·8 claims
- 1668US2025101136A1Enhanced targeting platformUNIV YALE·Filed 2024·Application pending·0 cites
- 1766US11492401B2Therapeutic musk antibodiesUNIV NEW YORK·Filed 2021·Granted Nov 8, 2022·0 cites·24 claims
- 1865US2025051474A1Anti-cd97 antibodies and antibody-drug conjugatesUNIV NEW YORK·Filed 2024·Application pending·0 cites
- 1963US2022178930A1Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 2063US2022185896A1Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 2162US12084500B2Antibodies specific to delta 1 chain of T cell receptorUNIV NEW YORK·Filed 2020·Granted Sep 10, 2024·0 cites·32 claims
- 2259US12049483B2Selective and noncovalent inhibitors of oncogenic RAS mutantsUNIV NEW YORK·Filed 2021·Granted Jul 30, 2024·0 cites·23 claims
- 2359US2024327460A1Nora inhibitors and methods of useUNIV NEW YORK·Filed 2022·Application pending·0 cites
- 2458US12162953B2Enhanced targeting platformUNIV YALE·Filed 2020·Granted Dec 10, 2024·0 cites·16 claims
- 2558US2025353912A1Compositions and methods comprising antibodies that bind to covalent peptide conjugatesUNIV NEW YORK·Filed 2023·Application pending·0 cites
- 2658US2024228668A1Compositions and methods comprising antibodies that bind to covalent peptide conjugatesUNIV NEW YORK·Filed 2022·Application pending·0 cites
- 2757US2024043543A1Anti-galectin-9 antibodies and therapeutic uses thereofUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 2857US2024109968A1Anti-galectin-9 antibodies and therapeutic uses thereofUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 2957US2022204629A1Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 3056US10208110B2Compositions and methods related to recombinant antibodies to histone posttranslational modificationsUNIV CHICAGO·Filed 2014·Granted Feb 19, 2019·0 cites·1 claims
- 3156US2023151091A1Therapeutic musk antibodiesARGENX IIP BV·Filed 2022·Application pending·0 cites
- 3254US2024025969A1Npc1 monobodies and monobody conjugates thereofUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 3354US2024016944A1Macropinocytosis selective monobody-drug conjugatesUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 3451US2022332832A1Combined cancer therapy of anti-galectin-9 antibodies and chemotherapeuticsUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 3542US11459400B2Methods and composition for modifying enzymesUNIV CHICAGO·Filed 2016·Granted Oct 4, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Akiko Koide files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →